Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fungi and cancer
Aurelia Saftien, Jens Puschhof, Eran Elinav
Gut (2023) Vol. 72, Iss. 7, pp. 1410-1425
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access | Times Cited: 4
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Intracellular bacteria in cancer—prospects and debates
Lena Schorr, Marius Mathies, Eran Elinav, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Dysbiosis and extraintestinal cancers
Rui He, Ping-Qian Qi, Lin-Zhen Shu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 7
Interplay between acetylation and ubiquitination of imitation switch chromatin remodeler Isw1 confers multidrug resistance in Cryptococcus neoformans
Meng Yang, Yue Ni, Zhuoran Li, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 6
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Candida albicans overgrowth impairs anti-PD-1 immunotherapy in oral tumor-bearing mice
Xu Wang, Xinming Zhang, Shuangshuang Wu, et al.
hLife (2025)
Open Access
Early-life gut mycobiome core species modulate metabolic health in mice
Mackenzie W. Gutierrez, Erik van Tilburg Bernardes, Ellen Ren, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Aspergillus flavus with Mycovirus as an Etiologic Factor for Acute Leukemias in Susceptible Individuals: Evidence and Discussion
Cameron K. Tebbi, Eva Sahakian, Bijal Shah, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 488-488
Open Access
Complex of intratumoral mycobiome and bacteriome predicts the recurrence of laryngeal squamous cell carcinoma
X. Mao, Huiying Huang, Limin Zhao, et al.
Applied and Environmental Microbiology (2025)
Open Access
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma
Weiming Mou, Zhe Deng, Lingxuan Zhu, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development
Xiaoyue Liang, Chen Ding, Jiannan Wang, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Candida albicans-myeloid cells-T lymphocytes axis in the tumor microenvironment of oral tumor-bearing mice
Xu Wang, Tiansong Xu, Shuangshuang Wu, et al.
Cancer Letters (2024) Vol. 588, pp. 216814-216814
Closed Access | Times Cited: 4
The evil companion of OSCC: Candida albicans
Zhixin Yang, Shiyu Zhang, Ning Ji, et al.
Oral Diseases (2023) Vol. 30, Iss. 4, pp. 1873-1886
Closed Access | Times Cited: 9
Microbes mediated immunogenic cell death in cancer immunotherapy
Jumin Huang, Fu‐Gang Duan, Chun Xie, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 128-142
Closed Access | Times Cited: 8
Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC
Tao Liu, Ya Guo, Yanxia Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
The role of intratumoral microorganisms in the progression and immunotherapeutic efficacy of head and neck cancer
Xuzhe Fang, Weihong Tong, Sheng Wu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 349-360
Open Access | Times Cited: 1
Gut mycobiome core species causally modulate metabolic health in mice
Marie‐Claire Arrieta
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
PWWP domain-containing protein Crf4-3 specifically modulates fungal azole susceptibility by regulating sterol C-14 demethylase ERG11
Ping Yu, Shuting Ye, Mi Zhou, et al.
mSphere (2024)
Open Access | Times Cited: 1
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
Kristin Moskal, Nimisha Khurana, Luisa Siegert, et al.
International Journal of Cancer (2024)
Open Access | Times Cited: 1
Race-dependent variability in the human tumor mycobiome
Dan Coster, Thomy Margalit, Ben Boursi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Preface to Special Edition: Microbiome, Inflammation and Cancer
Benjamin H. Mullish, Gianluca Ianiro
Best Practice & Research Clinical Gastroenterology (2024), pp. 101952-101952
Closed Access
The temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults
Wanglong Gou, Huijun Wang, Chang Su, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101775-101775
Open Access
Page 1 - Next Page

Scroll to top